Latest papers

Voacamine, an alkaloid extracted from Peschiera fuchsiaefolia, inhibits P-glycoprotein action in multidrug-resistant tumor cells.

Attenuation of morphine withdrawal signs by intracerebral administration of 18-methoxycoronaridine.

Natural medicines for alcoholism treatment: a review.

Quantitation of ibogaine and 12-hydroxyibogamine in human plasma by liquid chromatography with fluorimetric detection.

Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.

Addiction research. Ibogaine therapy: a 'vast, uncontrolled experiment'.

Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption.

GDNF and addiction.

Cytotoxic effects and reversal of multidrug resistance by ibogan and related indole alkaloids

Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.

Combating substance abuse with ibogaine: pre- and posttreatment recommendations and an example of successive model fitting analyses.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats

Administration of a non-NMDA antagonist, GYKI 52466, increases excitotoxic Purkinje cell degeneration caused by ibogaine.

[Ibogaine--the substance for treatment of toxicomania. Neurochemical and pharmacological action].

Voacamine, a bisindolic alkaloid from Peschiera fuchsiaefolia, enhances the cytotoxic effect of doxorubicin on multidrug-resistant tumor cells.

Ibogaine attenuation of morphine withdrawal in mice: role of glutamate N-methyl-D-aspartate receptors.

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.

Plant derivatives in the treatment of alcohol dependency.

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment.